Two-drug antiretroviral regimens for HIV
BMJ
.
2023 Sep 1:382:e071079.
doi: 10.1136/bmj-2022-071079.
Authors
John P Thornhill
1
2
,
Ben Cromarty
3
,
Jessica Gaddie
2
,
Shiellah Mushunje
3
,
Rashida A Ferrand
4
5
Affiliations
1
Blizard Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, UK j.thornhill@qmul.ac.uk.
2
Barts Health NHS Trust, London, UK.
3
UK Community Advisory Board (UK-CAB) HIV treatment advocates network.
4
Clinical Research Department, London School of Hygiene and Tropical Medicine, UK.
5
Biomedical Research and Training Institute, Harare, Zimbabwe.
PMID:
37657789
DOI:
10.1136/bmj-2022-071079
No abstract available
MeSH terms
Anti-HIV Agents* / therapeutic use
HIV Infections* / drug therapy
Humans
Substances
Anti-HIV Agents